PL2635583T3 - Pochodne koelenterazyny i metody ich wykorzystania - Google Patents

Pochodne koelenterazyny i metody ich wykorzystania

Info

Publication number
PL2635583T3
PL2635583T3 PL11785217T PL11785217T PL2635583T3 PL 2635583 T3 PL2635583 T3 PL 2635583T3 PL 11785217 T PL11785217 T PL 11785217T PL 11785217 T PL11785217 T PL 11785217T PL 2635583 T3 PL2635583 T3 PL 2635583T3
Authority
PL
Poland
Prior art keywords
methods
same
coelenterazine derivatives
coelenterazine
derivatives
Prior art date
Application number
PL11785217T
Other languages
English (en)
Polish (pl)
Inventor
Dieter H Klaubert
Poncho Meisenheimer
James Unch
Wenhui Zhou
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of PL2635583T3 publication Critical patent/PL2635583T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL11785217T 2010-11-02 2011-11-02 Pochodne koelenterazyny i metody ich wykorzystania PL2635583T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40941310P 2010-11-02 2010-11-02
PCT/US2011/058924 WO2012061477A1 (en) 2010-11-02 2011-11-02 Coelenterazine derivatives and methods of using same
EP11785217.8A EP2635583B1 (en) 2010-11-02 2011-11-02 Coelenterazine derivatives and methods of using same

Publications (1)

Publication Number Publication Date
PL2635583T3 true PL2635583T3 (pl) 2015-11-30

Family

ID=44999921

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11785217T PL2635583T3 (pl) 2010-11-02 2011-11-02 Pochodne koelenterazyny i metody ich wykorzystania

Country Status (15)

Country Link
US (1) US9487520B2 (enExample)
EP (1) EP2635583B1 (enExample)
JP (1) JP6040157B2 (enExample)
KR (1) KR101968475B1 (enExample)
CN (1) CN103180324A (enExample)
AU (1) AU2011323455B2 (enExample)
BR (1) BR112013010484B1 (enExample)
CA (1) CA2815381C (enExample)
DK (1) DK2635583T3 (enExample)
ES (1) ES2543913T3 (enExample)
IL (1) IL225869A (enExample)
PL (1) PL2635583T3 (enExample)
PT (1) PT2635583E (enExample)
SG (1) SG189494A1 (enExample)
WO (1) WO2012061477A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2635583B1 (en) 2010-11-02 2015-06-03 Promega Corporation Coelenterazine derivatives and methods of using same
AU2011323418B2 (en) 2010-11-02 2017-07-27 Promega Corporation Novel coelenterazine substrates and methods of use
WO2013033515A1 (en) * 2011-09-02 2013-03-07 Promega Corporation Compounds and methods for assaying redox state of metabolically active cells and methods for measuring nad(p)/nad(p)h
WO2014052653A1 (en) 2012-09-26 2014-04-03 Promega Corporation Real-time monitoring
CN105407723A (zh) 2013-03-15 2016-03-16 G1治疗公司 高效的抗赘生剂和抗增生剂
WO2014144326A1 (en) 2013-03-15 2014-09-18 G1 Therapeutics, Inc. Transient protection of normal cells during chemotherapy
JP6270127B2 (ja) * 2014-01-17 2018-01-31 国立研究開発法人物質・材料研究機構 ニコチンアデニンジヌクレオチド誘導体を検出する方法
US9927430B2 (en) 2014-01-29 2018-03-27 Promega Corporation Pro-substrates for live cell applications
JP6703484B2 (ja) * 2014-01-29 2020-06-03 プロメガ コーポレイションPromega Corporation 細胞による取り込み測定のための、標識用試薬としての、キノンでマスクされたプローブ
EP3313846B1 (en) 2015-06-25 2020-05-06 Promega Corporation Thienopyrrole compounds and uses thereof as inhibitors of oplophorus-derived luciferases
US9924073B2 (en) * 2016-02-15 2018-03-20 Promega Corporation Substituted imidazo[1,2-a]pyrazines as luciferase substrates and preparation method thereof
EP3490991B1 (en) 2016-07-28 2021-01-06 Promega Corporation Coelenterazine analogues
US10316070B2 (en) 2016-09-09 2019-06-11 Promega Corporation Dual protected pro-coelenterazine substrates
JP7200102B2 (ja) 2016-11-01 2023-01-06 プロメガ コーポレイション エネルギー受容体に係留されたセレンテラジン類縁体
DK3548492T5 (en) 2016-12-01 2024-08-05 Promega Corp Cell impermeable coelenterazine analogues
JP7161475B2 (ja) 2016-12-28 2022-10-26 プロメガ コーポレイション 官能化nanoluc阻害剤
EP3395803A1 (en) * 2017-04-28 2018-10-31 Institut Pasteur Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins
WO2019213119A1 (en) 2018-05-01 2019-11-07 Promega Corporation Coelenterazine compounds as nanoluc suicide substrates
US11390599B2 (en) 2018-06-01 2022-07-19 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes
KR102114088B1 (ko) * 2018-09-10 2020-06-17 (주)신우에이엔티 웨이퍼 세정용 나노 버블 분사 구조
CN119955899A (zh) 2018-10-03 2025-05-09 普洛麦格公司 用于稳定腔肠素及其类似物和衍生物的组合物、方法和试剂盒
BR112022010153A2 (pt) 2019-11-27 2022-08-09 Promega Corp Peptídeos, ácido nucleico, polipeptídeo, composição, complexo bioluminescente, métodos, dipeptídeo, sistema e kit
EP4073512B1 (en) 2019-12-10 2025-11-12 Promega Corporation Compositions and methods for bioluminescent detection using multifunctional probes

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3477549D1 (en) 1983-08-17 1989-05-11 Allied Signal Inc Gas generator and method of generating gas
JP3012274B2 (ja) * 1989-03-22 2000-02-21 日本臓器製薬株式会社 新規ルシフェリン誘導体
US5683888A (en) 1989-07-22 1997-11-04 University Of Wales College Of Medicine Modified bioluminescent proteins and their use
US5368484A (en) 1992-05-22 1994-11-29 Atari Games Corp. Vehicle simulator with realistic operating feedback
DE69535744T2 (de) 1994-01-03 2009-07-02 Promega Corp., Madison Mutierte luziferasen
US6387675B1 (en) 1994-01-03 2002-05-14 Promega Corporation Mutant luciferases
GB9501170D0 (en) 1994-03-23 1995-03-08 Secr Defence Luciferases
JP3648763B2 (ja) * 1994-08-23 2005-05-18 日本油脂株式会社 ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法
GB9417593D0 (en) 1994-09-01 1994-10-19 Secr Defence Luciferase labelling method
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
JP4342608B2 (ja) 1995-01-20 2009-10-14 スリーエム イノベイティブ プロパティーズ カンパニー 突然変異体ルシフェラーゼ
JPH08294397A (ja) 1995-04-27 1996-11-12 Nippon Oil & Fats Co Ltd 免疫学的活性物質の測定方法
US6522361B2 (en) 1996-03-08 2003-02-18 Sony Corporation Electronic apparatus having the function of displaying the battery residual quantity and method for displaying the battery residual quantity
JP4026876B2 (ja) * 1996-09-05 2007-12-26 日本食品化工株式会社 発光性シクロデキストリン誘導体及びその製造方法
US5998204A (en) 1997-03-14 1999-12-07 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
GB9707486D0 (en) 1997-04-11 1997-05-28 Secr Defence Enzyme assays
WO1998046739A1 (fr) 1997-04-16 1998-10-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Molecules immunomodulatrices et leur procede de production
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
JP4537573B2 (ja) 1997-09-19 2010-09-01 プロメガ・コーポレイシヨン 熱安定ルシフェラーゼと生産方法
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
JP3694181B2 (ja) 1999-01-05 2005-09-14 キッコーマン株式会社 変異型ルシフェラーゼ、変異型ルシフェラーゼ遺伝子、新規な組み換え体dna及び変異型ルシフェラーゼの製造法
GB9925161D0 (en) 1999-10-26 1999-12-22 Secr Defence Novel enzyme
EP1224294B1 (en) 1999-10-26 2007-10-03 The Secretary of State for Defence Mutant luciferase
US20010046687A1 (en) 2000-03-31 2001-11-29 Dicesare Joseph L. Method for the enhancement of luminescence intensity from a reaction between adenosine triphosphate (ATP) and a luciferase/luciferin reactant system
EP1156103B1 (en) 2000-04-26 2010-08-11 Chisso Corporation Oplophorus luciferase
JP4613441B2 (ja) 2000-04-26 2011-01-19 チッソ株式会社 新規ルシフェラーゼおよび発光蛋白質
US7118878B1 (en) 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
WO2002022854A2 (en) 2000-09-13 2002-03-21 Merck Patent Gmbh Method for the detection and measurement of biomass
US7268229B2 (en) 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
EP1472238B1 (en) 2002-02-01 2012-07-04 Promega Corporation Bioluminescent protease assay
ATE513838T1 (de) 2002-09-20 2011-07-15 Promega Corp Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivität
ES2237643T3 (es) * 2002-10-21 2005-08-01 Axxam S.R.L. Fotoproteina con bioluminiscencia mejorada.
JP4485470B2 (ja) 2002-12-23 2010-06-23 プロメガ コーポレイション ルシフェラーゼ酵素活性を保護するための方法及びキット
DE10303265A1 (de) 2003-01-28 2004-07-29 Roche Diagnostics Gmbh Fluorimetrische Bestimmung von Analyten durch ein intramolekulares Quencher-Fluorophor-Konjugat
EP1594962B1 (en) 2003-01-31 2014-08-27 Promega Corporation Covalent tethering of functional groups to proteins
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
EP1592805A1 (en) 2003-02-12 2005-11-09 Promega Corporation Methods and kits for dual enzymatic assays whereby light is quenched from luminescent reactions
US20040178545A1 (en) 2003-03-14 2004-09-16 Cates Larry E. System for optically analyzing a molten metal bath
EP2298902B1 (en) 2003-10-10 2015-04-22 Promega Corporation Luciferase biosensor
WO2005068483A1 (en) 2004-01-08 2005-07-28 Universität Zürich Metal complexes having vitamin b12 as a ligand
US7416854B2 (en) * 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US7553632B2 (en) 2004-01-22 2009-06-30 Promega Corporation Luminogenic and nonluminogenic multiplex assay
EP3179252B1 (en) 2004-07-30 2018-11-14 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US20070087400A1 (en) 2004-07-30 2007-04-19 Aldis Darzins Covalent tethering of functional groups to proteins and substrates therefor
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US7728118B2 (en) 2004-09-17 2010-06-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
JP4453528B2 (ja) * 2004-10-26 2010-04-21 東京化成工業株式会社 新規化学発光試薬
EP1700865A1 (en) 2005-03-11 2006-09-13 AXXAM S.r.l. Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators
JP4639904B2 (ja) 2005-03-30 2011-02-23 チッソ株式会社 蛍光活性を有するルシフェラーゼの活性増強方法
JP3844082B2 (ja) 2005-04-08 2006-11-08 キッコーマン株式会社 耐熱性ホタルルシフェラーゼ、耐熱性ホタルルシフェラーゼ遺伝子、新規な組み換え体dna及び耐熱性ホタルルシフェラーゼの製造法
EP1935986B1 (en) 2005-05-31 2014-04-16 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
WO2006130551A2 (en) 2005-05-31 2006-12-07 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
MX2008002123A (es) * 2005-08-17 2008-04-17 Yeda Res & Dev Metodos y composiciones para determinar un nivel de paraoxonasa de suero biologicamente activa.
JP4999341B2 (ja) 2005-09-06 2012-08-15 株式会社バイオエネックス 変異型ホタルルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型ホタルルシフェラーゼの製造方法
JP5684984B2 (ja) 2006-04-03 2015-03-18 プロメガ コーポレイションPromega Corporation 順列置換及び非順列置換ルシフェラーゼバイオセンサー
US8232047B2 (en) 2006-10-24 2012-07-31 Gene Stream Pty Ltd. Luciferase signal enhancing compositions
CA2667697A1 (en) 2006-10-30 2008-05-08 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and functional expression
WO2008086035A2 (en) 2007-01-10 2008-07-17 Promega Corporation Split mutant hydrolase fusion reporter and uses thereof
WO2008118445A1 (en) 2007-03-26 2008-10-02 Promega Corporation Methods to quench light from optical reactions
EP2215227A2 (en) 2007-11-05 2010-08-11 Promega Corporation Hybrid fusion reporter and uses thereof
ATE542903T1 (de) 2008-05-19 2012-02-15 Promega Corp Luciferase-biosensoren für camp
US8183007B2 (en) 2008-07-22 2012-05-22 Promega Corporation ADP detection based methods using adenylate cyclase and bioluminescence
TWI354101B (en) 2008-08-19 2011-12-11 Univ Nat Taipei Technology Fluorimetric indicator for biosensing and manufact
EP2420573A1 (en) 2009-04-17 2012-02-22 National Institute of Advanced Industrial Science And Technology Stable artificial bioluminescent enzyme having super-high brightness
KR101665352B1 (ko) 2009-05-01 2016-10-12 프로메가 코포레이션 광 출력이 향상된 합성 오플로포러스 루시퍼라제
WO2011038219A1 (en) 2009-09-24 2011-03-31 Promega Corporation Proteases having improved stability, solubility and activity
EP2569423B1 (en) 2010-05-11 2015-12-02 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
EP2611929B1 (en) 2010-09-01 2016-01-13 Promega Corporation Oxidized glutathione assay
US9284188B2 (en) 2010-09-03 2016-03-15 The Regents Of The University Of California Cytosolic delivery of materials with endosome-disrupting colloids
EP2635583B1 (en) 2010-11-02 2015-06-03 Promega Corporation Coelenterazine derivatives and methods of using same
AU2011323418B2 (en) 2010-11-02 2017-07-27 Promega Corporation Novel coelenterazine substrates and methods of use
WO2013033515A1 (en) 2011-09-02 2013-03-07 Promega Corporation Compounds and methods for assaying redox state of metabolically active cells and methods for measuring nad(p)/nad(p)h

Also Published As

Publication number Publication date
PT2635583E (pt) 2015-09-11
BR112013010484B1 (pt) 2019-09-03
EP2635583B1 (en) 2015-06-03
IL225869A (en) 2017-09-28
US20120107849A1 (en) 2012-05-03
WO2012061477A1 (en) 2012-05-10
ES2543913T3 (es) 2015-08-25
EP2635583A1 (en) 2013-09-11
US9487520B2 (en) 2016-11-08
JP2013544242A (ja) 2013-12-12
JP6040157B2 (ja) 2016-12-07
AU2011323455B2 (en) 2017-07-27
BR112013010484A2 (pt) 2016-07-05
KR101968475B1 (ko) 2019-04-15
IL225869A0 (en) 2013-07-31
CA2815381A1 (en) 2012-05-10
AU2011323455A1 (en) 2013-05-30
DK2635583T3 (en) 2015-08-03
KR20140003430A (ko) 2014-01-09
CA2815381C (en) 2019-03-19
SG189494A1 (en) 2013-05-31
CN103180324A (zh) 2013-06-26

Similar Documents

Publication Publication Date Title
IL225869A (en) Colentrazine derivatives and methods for their use
EP2536283B8 (en) Phenyl-heteroaryl derivatives and methods of use thereof
IL225867A0 (en) New substrates of kolantrazin
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
ZA201209205B (en) Pyridone and aza-pyridone compounds and methods of use
EP2539005A4 (en) ORAL PIECE AND METHODS OF USING THE SAME
LT3040424T (lt) Modifikuoti baltymai ir jų gavimo ir panaudojimo būdai
IL215251A0 (en) Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
IL220939A0 (en) Compounds and methods
IL223240A0 (en) Heteroaryl compounds and methods of use thereof
EP2523664A4 (en) COMPOUNDS AND METHODS
ZA201301120B (en) Heterocyclic compound and use thereof
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
AP4055A (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
IL220812A0 (en) Compounds and methods
ZA201208948B (en) Modified beta-lactamases and methods and uses related thereto
ZA201300036B (en) Banzamide derivatives and their use as hsp90 inhibitors
EP2523560A4 (en) CONNECTIONS AND METHODS
EP2552267A4 (en) HAIRSTYLE, AND METHOD OF USE THEREOF
ZA201300174B (en) Anti-neuropilin antibodies and methods of use
ZA201203076B (en) Spirolactam derivatives and uses of same
IL229968A0 (en) Tetrazolyloxy derivatives and methods for their production
PL2694532T3 (pl) Pochodne aureobasidin i sposoby syntezy
WO2012045019A9 (en) Brca deficiency and methods of use
GB201003268D0 (en) Accessory system and method of use thereof